BCL2L10 Antikörper (AA 101-194) (FITC)
Kurzübersicht für BCL2L10 Antikörper (AA 101-194) (FITC) (ABIN714888)
Target
Alle BCL2L10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 101-194
-
Kreuzreaktivität
- Maus, Ratte
-
Homologie
- Human,Cow,Pig,Chicken,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human BCL2L10
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BCL2L10 (BCL2-Like 10 (Apoptosis Facilitator) (BCL2L10))
-
Andere Bezeichnung
- Bcl2l10
-
Hintergrund
-
Synonyms: Boo, Diva, BCL-B, bcl2-L-10, Bcl-2-like protein 10, Anti-apoptotic protein NrH, Apoptosis regulator Bcl-B, BCL2L10, BCLB
Background: Promotes cell survival. Suppresses apoptosis induced by BAX but not BAK.
-
Gen-ID
- 10017
-
UniProt
- Q9HD36
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-